Activation of tyrosine hydroxylase prevents pneumonia in a rat chronic cerebral hypoperfusion model

Neuroscience

Volumn 158, Issue 2, 2009, Pages 665-672

  Zhang, N ^a   Miyamoto, N ^b   Tanaka, R ^b   Mochizuki, H ^a,b   Hattori, N ^b   Urabe, T ^b  

^a Research Institute for Disease of Old Age   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

cerebral hypoperfusion; dysphagia; neurotransmitters; phosphorylated CREB; post stroke pneumonia

Indexed keywords

CILOSTAZOL; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DOPAMINE; SUBSTANCE P; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DRUG MECHANISM; DYSPHAGIA; MALE; MEDULLA OBLONGATA; NEUROMODULATION; NONHUMAN; PATHOPHYSIOLOGY; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STROKE; SUBSTANTIA NIGRA; SWALLOWING; WESTERN BLOTTING;

ANIMALS; BACTERIA; CAROTID STENOSIS; CHRONIC DISEASE; CORPUS STRIATUM; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DEGLUTITION; DISEASE MODELS, ANIMAL; DOPAMINE; ENZYME ACTIVATION; FIBRINOLYTIC AGENTS; GENE EXPRESSION REGULATION; LIGATION; MALE; PNEUMONIA; RATS; RATS, WISTAR; REGIONAL BLOOD FLOW; SUBSTANCE P; SUBSTANTIA NIGRA; TETRAZOLES; TIME FACTORS; TYROSINE 3-MONOOXYGENASE;

EID: 58149461846     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2008.10.049     Document Type: Article

References (36)

1. Albin R.L., Young A.B., and Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci 12 (1989) 366-375
2. Arai T., Yoshimi N., Fujiwara H., and Sekizawa K. Serum substance P concentrations and silent aspiration in elderly patients with stroke. Neurology 61 (2003) 1625-1626
3. Ertekin C., Aydogdu I., Tarlaci S., Turman A.B., and Kiylioglu N. Mechanisms of dysphagia in suprabulbar palsy with lacunar infarct. Stroke 31 (2000) 1370-1376
4. Fosburgh L.C. From this point in time: some memories of my part in the history of anesthesia: John S. Lundy, MD. AANA J 65 (1997) 323-328
5. Gerfen C.R. The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci 15 (1992) 133-139
6. Graybiel A.M. Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci 13 (1990) 244-254
7. Gresham S.L. Clinical assessment and management of swallowing difficulties after stroke. Med J Aust 153 (1990) 397-399
8. Heuschmann P.U., Kolominsky-Rabas P.L., Misselwitz B., Hermanek P., Leffmann C., Janzen R.W., Rother J., Buecker-Nott H.J., Berger K., and German Stroke Registers Study Group. Predictors of in-hospital mortality and attributable risks of death after ischemic stroke: the German Stroke Registers Study Group. Arch Intern Med 164 (2004) 1761-1768
9. Hinchey J.A., Shephard T., Furie K., Smith D., Wang D., Tonn S., and Stroke Practice Improvement Network Investigators. Formal dysphagia screening protocols prevent pneumonia. Stroke 36 (2005) 1972-1976
10. Horner J., Massey E.W., Riski J.E., Lathrop D.L., and Chase K.N. Aspiration following stroke: clinical correlates and outcome. Neurology 38 (1988) 1359-1362
11. Hornykiewicz O. Dopamine (3-hydroxyramine) and brain function. Pharmacol Rev 18 (1966) 925-964
12. 18F-fluorodopa and PET. Ann Nucl Med 8 (1994) 245-251
13. Jin Y., Sekizawa K., Fukushima T., Morikawa M., Nakazawa H., and Sasaki H. Capsaicin desensitization inhibits swallowing reflex in guinea pigs. Am J Respir Crit Care Med 149 (1994) 261-263
14. Kajii Y., Shingai T., Kitagawa J., Takahashi Y., Taguchi Y., Noda T., and Yamada Y. Sour taste stimulation facilitates reflex swallowing from the pharynx and larynx in the rat. Physiol Behav 77 (2002) 321-325
15. Kimura K., Minematsu K., Kazui S., Yamaguchi T., and Japan Multicenter Stroke Investigators' Collaboration (J-MUSIC). Mortality and cause of death after hospital discharge in 10,981 patients with ischemic stroke and transient ischemic attack. Cerebrovasc Dis 19 (2005) 171-178
16. Kobayashi H., Nakagawa T., Sekizawa K., Arai H., and Sasaki H. Levodopa and swallowing reflex. Lancet 348 (1996) 1320-1321
17. Komine-Kobayashi M., Zhang N., Liu M., Tanaka R., Hara H., Osaka A., Mochizuki H., Mizuno Y., and Urabe T. Neuroprotective effect of recombinant human granulocyte colony-stimulating factor in transient focal ischemia of mice. J Cereb Blood Flow Metab 26 (2006) 402-413
18. Kross D.E. Adult aspiration pneumonia. Am Fam Physician 22 (1980) 73-78
19. Lee J.H., Park S.Y., Lee W.S., and Hong K.W. Lack of antiapoptotic effects of antiplatelet drug, aspirin and clopidogrel, and antioxidant, MCI-186, against focal ischemic brain damage in rats. Neurol Res 27 (2005) 483-492
20. Lewis-Tuffin L.J., Quinn P.G., and Chikaraishi D.M. Tyrosine hydroxylase transcription depends primarily on cAMP response element activity, regardless of the type of inducing stimulus. Mol Cell Neurosci 25 (2004) 536-547
21. Li S.J., Sivam S.P., McGinty J.F., Huang Y.S., and Hong J.S. Dopaminergic regulation of tachykinin metabolism in the striatonigral pathway. J Pharmacol Exp Ther 243 (1987) 792-798
22. Martino R., Foley N., Bhogal S., Diamant N., Speechley M., and Teasell R. Dysphagia after stroke: incidence, diagnosis, and pulmonary complications. Stroke 36 (2005) 2756-2763
23. Meisel C., Prass K., Braun J., Victorov I., Wolf T., Megow D., Halle E., Volk H.D., Dirnagl U., and Meisel A. Preventive antibacterial treatment improves the general medical and neurological outcome in a mouse model of stroke. Stroke 35 (2004) 2-6
24. Nagatsu T., Levitt M., and Udenfriend S. Tyrosine hydroxylase, the initial step in norepinephrine biosynthesis. J Biol Chem 239 (1964) 2910-2917
25. Nakagawa T., Ohrui T., Sekizawa K., and Sasaki H. Sputum substance P in aspiration pneumonia. Lancet 345 (1995) 1447
26. Pinto A., Yanai M., Nakagawa T., Sekizawa K., and Sasaki H. Swallowing reflex in the night. Lancet 344 (1994) 820-821
27. Ren Y.R., Nishida Y., Yoshimi K., Yasuda T., Jishage K., Uchihara T., Yokota T., Mizuno Y., and Mochizuki H. Genetic vitamin E deficiency does not affect MPTP susceptibility in the mouse brain. J Neurochem 98 (2006) 1810-1816
28. Salin P., Dziewczapolski G., Gershanik O.S., Nieoullon A., and Raisman-Vozari R. Differential regional effects of long-term L-DOPA treatment on preproenkephalin and preprotachykinin gene expression in the striatum of 6-hydroxydopamine-lesioned rat. Brain Res Mol Brain Res 47 (1997) 311-321
29. Shinohara Y., and Cilostazol Stroke Prevention Study (CSPS) Group. Antiplatelet cilostazol is effective in the prevention of pneumonia in ischemic stroke patients in the chronic stage. Cerebrovasc Dis 22 (2006) 57-60
30. Sivam S.P., and Cox J. Postnatal administration of D1 dopamine agonist reverses neonatal dopaminergic lesion-induced changes in striatal enkephalin and substance P systems. Brain Res 1073 (2006) 159-163
31. Ujiie Y., Sekizawa K., Aikawa T., and Sasaki H. Evidence for substance P as an endogenous substance causing cough in guinea pigs. Am Rev Respir Dis 148 (1993) 1628-1632
32. 3 receptor agonist delivery to a model of Parkinson's disease restores the nigrostriatal pathway and improves locomotor behavior. J Neurosci 26 (2006) 7272-7280
33. Walker A.E., Robins M., and Weinfeld F.D. The National Survey of Stroke. Clinic findings. Stroke 12 Suppl 1 (1981) I13-I44
34. Watanabe T., Zhang N., Liu M., Tanaka R., Mizuno Y., and Urabe T. Cilostazol protects against brain white matter damage and cognitive impairment in a rat model of chronic cerebral hypoperfusion. Stroke 37 (2006) 1539-1545
35. Xu M., Moratalla R., Gold L.H., Hiroi N., Koob G.F., Graybiel A.M., and Tonegawa S. Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in the dopamine-mediated behavioral responses. Cell 79 (1994) 729-742
36. Zhou Q.Y., and Palmiter R.D. Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic. Cell 83 (1995) 1197-1209